Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Santarus, Inc.    SNTS   US8028173040

SANTARUS, INC. (SNTS)

13
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancials 
Company
Sector
Pharmaceuticals
Calendar
03/02Earnings Release
More about the company
Chart SANTARUS, INC.
Duration : Period :
Santarus, Inc. Technical Analysis Chart | SNTS | US8028173040 | 4-Traders
Full-screen chart
Latest news on SANTARUS, INC.
01/14 SALIX PHARMACEUTICALS, LTD. : Salix Pharmaceuticals Purchases Santarus
01/08 SALIX PHARMACEUTICALS, LTD. : Salix Pharmaceuticals Acquires Santarus
01/08 SALIX PHARMACEUTICALS, LTD. : Salix Pharmaceuticals Acquires Santarus
01/06 SALIX PHARMACEUTICALS, LTD. : Salix Pharmaceuticals acquires Santarus
01/03 SANTARUS, INC. : Salix Pharmaceuticals announces completion of acquisition of Sa..
01/02 Nasdaq stocks posting largest volume decreases
01/02 SANTARUS, INC. : SANTARUS INC FILES (8-K) Disclosing Completion of Acquisition o..
2013 SANTARUS, INC. : Relocation Plans, Patient Enrollment, Management Appointments, ..
More news
Sector news
1h ago AstraZeneca CEO says new Pfizer bid unlikely - Swedish daily DI
1d ago JAZZ PHARMACEUTICALS : Receives FDA Approval For Intravenous Administration Of E..
1d ago CUBIST PHARMACEUTICALS : FDA OKs Cubist antibiotic for serious infections
More sector news
4-Traders Strategies on SANTARUS, INC. 
2013Continuation of the bullish trend
2013Still a great upward potential
More Strategies


Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF